Search

Search Constraints

You searched for: Author/Creator Hugon, Jacques

Search Results

61. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions. Issue 3 (1st March 2019)

62. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study. Issue 12 (20th February 2022)

63. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Issue 7 (16th February 2018)

64. Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients. Issue 4 (28th November 2022)

65. Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment. (12th February 2014)

67. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease. Issue 1 (December 2016)

69. Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study. Issue 1 (December 2016)

70. What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France. Issue 5 (30th May 2019)